Xin Lu

机构：Wenzhou Medical University, China-Japan Friendship Hospital, First Affiliated Hospital of Wenzhou Medical University, Morristown Medical Center, Sanofi (United States), C3I (United States)

发表论文 67 篇 · 总被引 1614 次 · h-index 21

代表论文

• Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress (2023 · Nature Reviews Rheumatology · 被引 156)
• Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials (2025 · The Lancet Respiratory Medicine · 被引 73)
• Dupilumab Improves Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation: BOREAS and NOTUS (2025 · CHEST Journal · 被引 14)
• On-Device Pressure-Tunable Moving Schottky Contacts (2024 · Nano Letters · 被引 14)
• Prevalence, Risk Factors, and Mortality of Invasive Pulmonary Aspergillosis in Patients with Anti-MDA5+ Dermatomyositis: A Retrospective Study in China (2024 · Journal of Inflammation Research · 被引 13)
• Efficacy and safety of dupilumab with concomitant topical corticosteroids in Japanese pediatric patients with moderate-to-severe atopic dermatitis: A randomized, double-blind, placebo-controlled phase 3 study (2024 · Allergology International · 被引 11)